Fakultni nemocnice Brno Neurologicka klinika
About Fakultni nemocnice Brno Neurologicka klinika
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Grifols Therapeutics LLC
3
Supernus Pharmaceuticals, Inc.
2
Institut de Recherches Internationales Servier
1
Ipsen
1
Clinical Trials at Fakultni nemocnice Brno Neurologicka klinika
During the past decade, Fakultni nemocnice Brno Neurologicka klinika conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on
average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Assess the Efficacy and Safety of IGIV-C in Patients With Myasthenia Gravis Exacerbations
2015-03-01
2018-04-01
Completed
49
A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis
2015-08-01
2018-01-01
Completed
62
Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
2015-06-01
2019-02-01
Completed
60
Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event
2016-12-19
2019-03-10
Completed
585
Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC)
2016-12-18
2018-07-01
Completed
157
Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity
2019-12-17
2024-07-01
Active, not recruiting
272
Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity
2021-11-16
2024-07-01
Active, not recruiting
272
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Fakultni nemocnice Brno Neurologicka klinika"
#1 collaborator was "Solstice Neurosciences" with 2 trials as a collaborator and "ADIR, a Servier Group company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Fakultni nemocnice Brno Neurologicka klinika
According to Clinical.Site data, the most researched conditions in "Fakultni nemocnice Brno Neurologicka klinika" are
"Spasticity" (2 trials), "Cerebral Palsy" (1 trials), "Cerebrovascular Accident" (1 trials), "Cervical Spinal Cord Injury" (1 trials) and "Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Fakultni nemocnice Brno Neurologicka klinika" in a lesser frequency.
Clinical Trials Intervention Types at Fakultni nemocnice Brno Neurologicka klinika
Most popular intervention types in "Fakultni nemocnice Brno Neurologicka klinika" are "Drug" (5 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "IGIV-C" (3 trials), "Placebo" (3 trials), "Phase 2; High Dose MYOBLOC" (2 trials), "Phase 2; Low Dose MYOBLOC" (2 trials) and "Phase 2; Placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Fakultni nemocnice Brno Neurologicka klinika
The vast majority of trials in "Fakultni nemocnice Brno Neurologicka klinika" are
7 trials for "All" genders.
Clinical Trials Status at Fakultni nemocnice Brno Neurologicka klinika
Currently, there are NaN active trials in "Fakultni nemocnice Brno Neurologicka klinika".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Fakultni nemocnice Brno Neurologicka klinika,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Fakultni nemocnice Brno Neurologicka klinika, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".